Drug development today needs to balance agility, speed, and risk
in defining probability of success for molecules, mechanisms, and
therapeutic concepts. New techniques such as fMRI promise to be
part of a sequence that could transform drug development. Although
numerous review articles exist that discuss the use of imaging in
drug development, no one source is available that combines the
various techniques and includes a discussion of disease
mapping.
Imaging in CNS Drug Discovery and Development, Implications for
Disease and Therapy will serve to distill the most salient
developments in the use of imaging in drug development and disease
mapping. It will launch evolving concepts that integrate new
imaging technologies and paradigms with molecular medicine and
molecular profiling ("monics") as well as consider the ethical
issues that arise as a result of disease or state diagnosis and the
use of imaging in the public eye.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!